Extraribosomal function of metallopanstimulin-1: reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth
✍ Scribed by Yuemeng Dai; Spencer E. Pierson; W. Cross Dudney; Brendan C. Stack Jr.
- Book ID
- 102862927
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 558 KB
- Volume
- 126
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Metallopanstimulin‐1 (MPS‐1) is a multifunctional ribosomal protein RPS27 that contains a zinc finger domain of the C~4~ type. MPS‐1 has been found to be increased in the sera of a number of different cancers, including head and neck squamous cell carcinoma (HNSCC). However, little is known about the effect of a high‐level MPS‐1 in regulating cancer cell behavior. In this study, we overexpressed MPS‐1 protein in the HNSCC cell line UMSCC‐1. We found MPS‐1 distributes not only in the cytosol, but also in the nuclei. In addition, MPS‐1 is secreted into the culture medium. In vitro and in vivo experiments show that growth of UMSCC‐1 cells transfected with MPS‐1 is dramatically inhibited. Moreover, we also found that with overexpressing MPS‐1, UMSCC‐1 cells were arrested on G0/G1 phase, cell proliferation rate was reduced, and tumor angiogenesis was impaired. Further gene array analysis, immunohistochemistry staining and Western blotting reveal that MPS‐1 reduces paxillin mRNA and protein levels in UMSCC‐1 cells both in vitro and in vivo. Together, these data indicate that when MPS‐1 is overexpressed, it has an extraribosomal function as a strong inhibitor of HNSCC tumor cell growth, which may be exerted by reduced paxillin gene expression.
📜 SIMILAR VOLUMES
Background. The progression of tumor growth requires the recruitment of new blood vessels. It has been suggested that the degree of neovascularization would correlate with clinical prognosis. The purpose of the present study was to ascertain whether tumor vascularization correlated with clinical out